CanVasc Webinar Series

2022 ANCA Workshop Update
June 22nd, 2022 7:30-8:30pm EST

After attending this event, participants will be better able to:

Identify the key points presented at the EULAR conference and incorporate these into clinical practice;
Utilize new evidence for the management of EGPA, GPA and MPA;
Consider various perspectives on current controversies in any vasculitis

Christian Pagnoux, MD, MSc, MPH

Associate Professor, University of Toronto

Sinai Hospital

Toronto, ON Canada

Mats Junek, MD, MSc

Rheumatology Fellow, McMaster University

St. Joseph's Healthcare

Hamilton, ON Canada

Natasha Dehghan, MD, FRCPC

Clinical Assistant Professor, University of BC

Mary Pack Arthritis Centre

Vancouver, BC Canada

ANCA Vasculitis, Diagnostics, and Management: A personal story of more than 35 years of experience with ANCA determinations.
September 27th, 2022 7:30-8:30pm EST

After attending this event, participants will be better able to:

Understand the development and identification of ANCA as a biomarker (pathogenesis info);
Apply clinical strategies for the use of ANCA in the diagnosis and follow-up in ANCA Vasculitis;
Appreciate and consider new advances for the role of ANCA in the management of vasculitis

Moderated by:

Speaker:

Jan Willem Cohen Tervaert, MD, PhD

Professor, Director, Division Rheumatology

University of Alberta

Edmonton, AB Canada

Emeritus Professor of Medicine and Immunology

Maastricht University, The Netherlands

Lillian Barra, MD, MPH, FRCPC

Associate Professor

Schulich School of Medicine and Dentistry

University of Western Ontario

London, ON Canada

EULAR Recommendations for the Management of ANCA-Associated Vasculitis: 2022 Update
October 17th, 2022 12:30-1:30pm EST

After attending this event, participants will be better able to:

Identify the key points presented at the EULAR conference and incorporate these into clinical practice;
Utilize new evidence for the management of EGPA, GPA and MPA;
Consider various perspectives on current controversies in any vasculitis

Bernhard Hellmich, MD, Professor of Medicine

University of Tübingen

Medius Kliniken, Department of Internal Medicine,

Rheumatology & Immunology

Kirchheim unter Teck, Germany

Lillian Barra, MD, MPH, FRCPC

Associate Professor

Schulich School of Medicine and Dentistry

University of Western Ontario

London, ON Canada

Update from the FVSG (French Vasculitis Study Group)
French Presentation: February 3rd, 2023 12:00-1:00pm EST || English Presentation: February 14th, 2023 12:00-1:00pm EST

After attending this event, participants will be better able to;

Evaluate the duration and regimens for remission-maintenance in ANCA-associated vasculitis;
Consider the use of rituximab in Eosinophilic granulomatosis with polyangiitis (EGPA).

Benjamin Terrier, MD, PhD
Internal Medicine
National Referral Center for Autoimmune Diseases
Hôpital Cochin, Paris, France

*French Presentation

*English Presentation

Vasculitis Updates from ACR and the ASN

Thursday December 14, 2023, 7:00-8:00pm EST

After attending this event, participants will be better able to:

Identify the key points presented at the ACR and the ASN and incorporate these into clinical practice;
Utilize new evidence for the management of vasculitis;
Consider various perspectives on current updates in vasculitis.

Bryce Barr, MD

Associate Professor

University of Manitoba

Winnipeg, MB

Stephanie Garner, MD, MSc, FRCPC

Clinical Assistant Professor

University of Calgary

Calgary, AB

Lillian Barra, MD, MPH, FRCPC

Associate Professor

Schulich School of Medicine and Dentistry

London, ON

Recommendations for the Management of EGPA

Thursday March 14, 2024 1:00-2:00pm EST

After attending this event, participants will be better able to:

Differentiate between EGPA and other disorders; how to develop the diagnostic work up.
Identify the main patient characteristics that guide treatment in EGPA (FFS, other clinical manifestations)
Consider the main treatment approaches for severe vs non severe EGPA and for newly diagnosed vs relapsing disease.
Identify the differences between the European and US EGPA guidelines.

Christian Pagnoux, MD, MSc, MPH

Associate Professor, Founder and Vice-Director of CanVasc
Mount Sinai Hospital
Vasculitis Clinic, Division of Rheumatology
Department of Medicine, University of Toronto

Augusto Vaglio, MD, PhD

Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Italy
Nephrology and Dialysis Unit, Meyer Children’s Hospital, Florence, Italy